Bromide

Bromide

SCHEMBL582480

CCCC[n+]1ccn(C)c1.CCCC[n+]1ccn(C)c1.CCCC[n+]1ccn(C)c1.[Br-].[Br-].[Br-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL193080 1.00
Methane SCHEMBL28840387 0.98
Bromide SCHEMBL28471019 0.98
SCHEMBL28238039 0.98 ABCB11 (0.39)
Fluoride SCHEMBL26122977 0.98 ABCB11 (0.39)
Fluoride SCHEMBL28788477 0.98 ABCB11 (0.39)
Fluoride SCHEMBL28437282 0.98 ABCB11 (0.39)
SCHEMBL34968 0.98 ABCB11 (0.39)
Bromide SCHEMBL28213694 0.96
Hydrochloric Acid SCHEMBL28055324 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4267591-A2 ORGANOMETALLIC COMPOUNDS Umicore AG & Co. KG (DE) 2023-11-01 EP claimed
WO-2022136049-A2 ORGANOMETALLIC COMPOUNDS UMICORE AG & CO. KG (DE) 2022-06-30 WO claimed
CN-112451665-B NIR-II diagnosis and treatment integrated silicon-carbon nanoprobe and preparation method thereof 山西医科大学 2022-06-21 CN claimed
US-11344858-B2 Micro-electrolysis reactor for ultra fast, oxidant free, C—C coupling reaction and synthesis of daclatasvir analogs thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH 2022-05-31 US claimed
CN-114334477-A Intelligent super capacitor and preparation method thereof 东莞东阳光科研发有限公司 2022-04-12 CN claimed
CN-112451665-A Novel NIR-II diagnosis and treatment integrated silicon-carbon nanoprobe and preparation method thereof 山西医科大学 2021-03-09 CN claimed
US-20200346182-A1 MICRO-ELECTROLYSIS REACTOR FOR ULTRA FAST, OXIDANT FREE, C-C COUPLING REACTION AND SYNTHESIS OF DACLATASVIR ANALOGS THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2020-11-05 US claimed
US-10673094-B2 Rechargeable non-aqueous Mg—Br2 battery TRUSTEES OF BOSTON COLLEGE (US) 2020-06-02 US claimed
US-20180323466-A1 RECHARGEABLE NON-AQUEOUS MG-BR2 BATTERY Boston College Office of Technology Transfer and Licensing (US) 2018-11-08 US claimed
WO-2016178250-A1 PROCESS FOR THE PREPARATION OF DACLATASVIR MYLAN LABORATORIES LIMITED (IN) 2016-11-10 WO claimed
US-20150162213-A1 FORMULATIONS FOR WET ETCHING NIPT DURING SILICIDE FABRICATION ADVANCED TECHNOLOGY MATERIALS, INC. (US) 2015-06-11 US claimed
EP-2847364-A1 FORMULATIONS FOR WET ETCHING NIPT DURING SILICIDE FABRICATION Entegris, Inc. (US) 2015-03-18 EP claimed
WO-2013170130-A1 FORMULATIONS FOR WET ETCHING NIPT DURING SILICIDE FABRICATION ADVANCED TECHNOLOGY MATERIALS, INC. (US) 2013-11-14 WO claimed
US-12623988-B2 Scaleable preparation of polyketides THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2026-05-12 US disclosed
US-12600743-B2 Method for producing oligonucleic acid compound NIPPON SHINYAKU CO., LTD. (JP) 2026-04-14 US disclosed
US-12576365-B2 Spiral membrane element and membrane separation system NITTO DENKO CORPORATION (JP) 2026-03-17 US disclosed
EP-2094645-A1 2-HYDROXY-1,3-DIAMINOPROPANE DERIVATIVES Novartis AG (CH) 2009-09-02 EP disclosed
WO-2009024615-A1 AMINOBENZYL-SUBSTITUTED CYCLIC SULFONES USEFUL AS BACE INHIBITORS NOVARTIS AG (CH) 2009-02-26 WO disclosed
US-20090054427-A1 AMINOBENZYL-SUBSTITUTED CYCLIC SULFONES USEFUL AS BACE INHIBITORS BRIARD EMMANUELLE 2009-02-26 US disclosed
WO-2008062044-A1 2-HYDROXY-1,3-DIAMINOPROPANE DERIVATIVES NOVARTIS AG (CH) 2008-05-29 WO disclosed